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Abstract
Background: Class II phosphoinositide 3-kinase α-isoform (PI3K-C2α) is involved in regulating KCl-induced vascular
smooth muscle contraction. The current study was to investigate the effects of sevoflurane (SEVO) and isoflurane
(ISO) on KCl-elicited PI3KC2α mediated vasoconstriction in rat aortic smooth muscle.
Methods: Isometric force, in the absence or presence of SEVO or ISO (1 ~ 3 minimum alveolar concentration, MAC),
PI3K inhibitor LY294002, Rho kinase inhibitor Y27632, and membrane translocation of PI3K-p85, PI3K-C2α, Rho kinase
(Rock II), or phosphorylation of MYPT1/Thr853, MYPT1/Thr696, CPI-17/Thr38 and MLC in response to KCl (60 mM)
was measured by using isometric force transducer and western blotting analysis, respectively.
Results: KCl elicited a rapid and sustained contraction of rat aortic smooth muscle that was inhibited by both SEVO
and ISO in a concentration-dependent manner, and also suppressed by LY294002 (1 mM) and Y27632 (1 uM).
LY294002 (1 mM) and Y27632 (1 uM) also inhibited KCl-induced MLC phosphorylation. LY294002 (1 mM) inhibited
KCl-induced PI3K-p85, PI3K-C2α membrane translocation in response to KCl (p <0.05, p < 0.01, respectively). Not only
Y27632 (1 uM), but also LY294002 (1 mM), inhibited KCl-induced Rock-II membrane translocation (p < 0.01). SEVO
and ISO inhibited KCl-stimulated MLC phosphorylation, PI3K-C2α and Rock-II,not PI3K p85 membrane translocation
in a concentration-dependent manner in rat aorta. Both SEVO and ISO suppressed the MYPT1/Thr853, not MYPT1/
Thr696 and CPI-17/Thr38, MLC phosphorylation in response to KCl.
Conclusion: PI3K-C2α mediates part of SEVO and ISO-mediated vasodilation in rat aorta. The cellular mechanisms
underlying the inhibitory effect of volatile anesthetics might be mediated by KCl/PI3K-C2α/Rho kinase/MYPT1/MLC
pathway.
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Background
The mechanism of KCl-stimulated vascular smooth muscle
(VSM) contraction may involve Ca2+-dependent and Ca2+
sensitization pathways. Membrane depolarization by KCl
increases Ca2+ influx via voltage-dependent Ca2+ channel
receptors on VSM cells, leading to an increase in cytosolic
free Ca2+ ([Ca2+]i). This increase in [Ca
2+]i activates
Ca2+-calmodulin-dependent myosin light chain kinase,
resulting in MLC phosphorylation and vascular
contraction [1–4]. In addition to the Ca2+-dependent
pathway, the Ca2+-induced Ca2+ sensitization pathway
may also regulate MLC phosphatase (MLCP) through
modulation of class II phosphoinositide 3 kinase α sub-
unit (PI3K-C2α) and Rho kinase activity, which results
in vascular contraction [5–8] (Fig. 1).
PI3Ks are a ubiquitously expressed enzyme family that
phosphorylates membrane inositol lipids and exert di-
verse biological activities [9, 10]. PI3Ks are divided into
three main classes. VSM is known to express multiple
PI3Ks, including the class I enzymes p110α and p110β,
and class II enzymes PI3K-C2α and C2β [11].
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Several studies show that sevoflurane (SEVO) and iso-
flurane (ISO) can provide protection against ischemia-
reperfusion injury via the PI3K/Akt pathway [12–15]. In
contrast, volatile anesthetics can result in some compli-
cations, such as hypertension, particularly at higher con-
centrations. The mechanism may involve relaxation of
VSM directly through intracellular signaling transduc-
tion pathways [1, 16–18]. However, the exact mechanism
is not fully understood.
We previously demonstrated that SEVO inhibited
GTPγ S-stimulated Rho-Rho kinase-mediated vasocon-
striction in isolated rat aortic VSM [16]. We also revealed
that SEVO attenuated Angiotensin II (Ang II)-induced
vasoconstriction by reducing PKC phosphorylation
without affecting [Ca2+]i in VSM [17]. We recently
demonstrated that SEVO inhibited MLC, the PKC-
potentiated inhibitory protein CPI-17, and myosin
phosphatase target subunit MYPT1/Thr853 phosphor-
ylation in response to Ang II. ISO also inhibited MLC
phosphorylation in response to Ang II, which was asso-
ciated with a decrease in MYPT1/Thr853, but not in
CPI-17 phosphorylation. Neither SEVO nor ISO af-
fected Ang II-induced phosphorylation of MYPT1/
Thr696 [18]. However, little information is available
about the effect of SEVO and ISO on Ca2+-induced
Ca2+ sensitization in regulating VSM contraction. The
current study involved investigating the effects of
volatile anesthetic modulation of PI3K subunit and
Rho kinase activity on vasoconstriction in response to
KCl in rat isolated aortic smooth muscle.
Fig. 1 Schematic illustration of volatile anesthetics on Ca2+-induced Ca2+ sensitization. VSM = vascular smooth muscle, GPCR = G protein coupled
receptor, G12/13 = 12/13 subunit of heterotrimeric G-protein; Gq = q subunit of heterotrimeric G-protein, PLC = phospholipase C, IP3 = inositol
1,4,5-triphosphate, DAG = diacylglycerol, PKC = protein kinase C, CPI-17 = PKC-potentiated inhibitory protein, KCl = potassium chloride, CaM= calmodulin,
PI3K-C2α = Class II phosphoinositide 3 kinase α-isoform, Rho kinase = small GTPase ROCK II, MLC =myosin light chain, p-MLC = phosphorylated MLC,
MLCK =MLC kinase, MLCP =MLC phosphatase, MYPT1/853 =myosin phosphatase target subunit Thr853, MYPT1/696 =myosin phosphatase target
subunit Thr696, PP1 = catalytic subunit of Type 1 protein phosphatase, M20 = accessory 20 kDa subunit, Dotted line = inhibitory effect
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Methods
Vascular smooth muscle tissue preparation
This protocol was approved by Shandong University
Animal Care and Use Committee and Qilu Hospital of
Shandong University Medical Ethics Committee (No.
KYLL-2013-51). Aortic rings and strips were prepared
according to previous protocols [16–18]. Male Wistar
rats (250–350 g) were anesthetized with halothane and
euthanized by exsanguination from the common ca-
rotid artery. The descending thoracic aorta was care-
fully dissected, and adherent fat and connecting tissue
were removed. The endothelium was removed by gen-
tle rubbing of the internal surface with a stainless steel
needle.
Isometric force measurement
In this study, KCl (60 mM) was used as an agonist ac-
cording to previous results [7]. KCl-elicited tension was
measured using isometric force methods as described
previously [16–18]. Briefly, endothelium-denuded aortic
rings were equilibrated under a resting tension of 3 g in
Krebs bicarbonate solution (KBS) (in mmol/L, NaCl,
118.2; KCl, 4.6; CaCl2, 2.5; KH2PO4, 1.2; MgSO4, 1.2;
NaHCO3, 24.8; and dextrose 10) at 37 °C and gassed
with a mixture of 95 % (v/v) O2 and 5 % (v/v) CO2 with
a fresh gas flow of 2 L/min. After 60 min equilibration,
with the bathing fluid replaced every 20 min, the aortic
rings were incubated with KCl (60 mM) to access their
overall contractile responsiveness. Removal of the endo-
thelium was confirmed with 3 × 10−7 M phenylephrine
pre-contracted vessels that showed a lack of relaxation
in the presence of 10−5 M acetylcholine. To examine the
effect of anesthetics on KCl-induced contraction, six aor-
tic rings from each individual rat (n = 7) were randomly
exposed to 0, 1, 2, and 3 minimum alveolar concentra-
tion (MAC) of each anesthetic, 1 mM LY294002 (PI3K
inhibitor), or 1 μM Y27632 (Rho kinase inhibitor) for
15 min before the addition of KCl (Fig. 2). Isometric
force development in response to KCl was expressed as
a percentage relative to that induced by KCl.
SEVO or ISO was delivered into the gas mixture with
a fresh gas flow of 2 L/min via a calibrated agent-specific
vaporizer (Penlon, Abingdon, UK) to aerate the KBS
with equivalent human MAC. The concentration of the
resulting gas mixture was monitored and adjusted using
an Atom 303 anesthetic agent monitor (Atom, Tokyo,
Japan). Our previous data using the same experimental
system indicated that the concentrations of SEVO or
ISO in KBS measured by gas chromatography (Shimazu
Seisakusho, Tokyo, Japan) were 0.17, 0.28, and 0.41 mM
for gas concentrations of 1.7 % (1 MAC), 3.4 % (2
MAC), and 5.1 % (3 MAC) SEVO, respectively (n = 8–12)
and 0.19, 0.39, and 0.56 mM for gas concentrations of
1.2 % (1 MAC), 2.3 % (2 MAC), and 3.5 % (3 MAC) ISO,
respectively (n = 8–12), after 15 min of equilibration.
Phosphorylation of MYPT1, CPI-17, and MLC
For measurement of MYPT1, CPI-17, and MLC phos-
phorylation, the endothelium-denuded strips (approxi-
mately 3.5 cm in length) were bathed in oxygenated KBS
and were equilibrated for 60 min before the start of the
experiment. One strip was obtained from each animal.
Previous data demonstrated that KCl (60 mM) induced
a rapid increase in MLC phosphorylation and reached
peak levels approximately 5 min after exposure to KCl
[8]. Therefore, the later experiments were examined
5 min after the application of KCl. Aortic strips from dif-
ferent animals were incubated with 0 (control), 60 mM
KCl, 1 MAC SEVO, 2 MAC SEVO, 1 mM LY294002,
and 1 μM Y27632, or 0 (control), 60 mM KCl, 1 MAC
ISO or 2 MAC ISO, 1 mM LY294002, and 1 μM Y27632
for 15 min without KCl or 5 min in the presence of KCl,
and were quickly frozen with liquid nitrogen. Thereafter,
protein phosphorylation was measured using western
blotting analysis as described previously [10–12]. Briefly,
the frozen strips were cut into small pieces and
Fig. 2 The protocol of sevoflurane, isoflurane, LY294002 and Y27632 on KCl-induced contraction of rat aortic smooth muscle. X axis = Time (min),
Y axis = Tension (g), W = wash, S = stop, ISO = isoflurane, SEVO = sevoflurane, MAC =minimum alveolar concentration, Y = Y27632, LY = LY294002,
Phe = phenylephedrine, Ach = acetylcholine
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homogenized in ice-cold lysis buffer with 0.2 % (v/v) Tri-
ton X-100. Homogenates were centrifuged at 10,000 g
for 30 min at 4 °C. The supernatants were assayed for
protein concentration using the bicinchoninic acid
method [13] and subsequently used for detection of
MYPT1, CPI-17, and MLC phosphorylation.
In each experiment, proteins (30 μg) were separated
by sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis (12 % or 5 %) and transferred to nitrocellulose
membranes. Membranes were incubated with anti-MLC,
anti-CPI-17, anti-MYPT1/Thr696, anti-MYPT1/Thr853
(1:1000, 1:1000, 1:500, and 1:500, respectively), and
antiphospho-MLC, antiphospho-CPI-17, antiphospho-
MYPT1/Thr696, and antiphospho-MYPT1/Thr853 anti-
bodies (1:1000, 1:1000, 1:500, and 1:500, respectively) for
2 h, followed by incubation with a horseradish
peroxidase-conjugated antibody (1:2000) for 1 h [12].
The densities of immunoreactive bands were detected
using chemiluminescence (Amersham Pharmacia Bio-
tech, Piscataway, NJ, USA) and were assessed with image
analysis software (NIH Image 1.62; National Institute of
Health, Bethesda, MD, USA). Bands with molecular
weights of 17 kDa, 20 kDa, and 110 kDa were identified
as CPI-17, MLC, and MYPT1, respectively. The ratios of
phosphorylated to total CPI-17, MLC, and MYPT1 were
used as an indicator of activation of each enzyme and
expressed as the percentage relative to the baseline con-
trol level (referred to as 100 %).
Membrane translocation of PI3K and Rho kinase (Rock II)
For enzyme membrane translocation, PI3K and Rho kin-
ase (Rock II) activity were measured using western blot-
ting analysis as described previously [16]. Briefly, the
endothelium-denuded aortic strips were bathed in 20-
mL organ chambers containing KBS solution. The strips
were equilibrated for 60 min in control KBS, which was
replaced every 20 min. To measure the dose effect of
SEVO, ISO, and kinase inhibition on KCl-stimulated
membrane translocation of PI3K or Rock II, some aortas
were treated with either 1.7 % SEVO, 3.5 % SEVO, 1.2 %
ISO, 2.3 % ISO, 1 mM LY294002, or 1 μM Y27632 for
15 min before exposure to KCl. After treatment with
KCl for 5 min, the samples were then rapidly frozen with
liquid nitrogen.
Frozen aortas were cut into small pieces and were ho-
mogenized in ice-cold lysis buffer containing 1 mM
Tris/HCl, pH 7.5, 5.5 mM MgCl2, 100 mM NaCl, 2 mM
EDTA, 1 mM 4-(2-aminoethyl) benzonesulfonyl fluoride,
20 μg/mL leupeptin, 20 μg/mL aprotinin, and 1 mM
Na3VO4. Homogenates were centrifuged at 13,000 g for
15 min at 4 °C, and the supernatants were collected and
centrifuged at 100,000 g for 30 min at 4 °C again. The
supernatant (cytosolic fraction) was removed, and the pel-
let (membrane fraction) was re-suspended using the same
lysis buffer. The protein concentrations of each fraction
were determined using the bicinchoninic acid method [19].
Equal amounts of total protein (30 μg) were used for
every sample in each experiment. Proteins were sepa-
rated by 7.5 % or 12 % sodium dodecyl sulfate-
polyacrylamide gel electrophoresis and were transferred
to a nitrocellulose membrane. The membrane was
treated with anti-PI3K-p85α, anti-PI3K-C2α, and anti-
Rock-II antibodies (1:200, 1:200, and 1:500, respectively)
for 4 h, followed by incubation with a horseradish
peroxidase-conjugated antibody (1:2000) for 1 h. Immu-
noreactive bands were detected using chemilumines-
cence (Amersham Pharmacia Biotech, Piscataway, NJ,
USA) and were assessed with image analysis software
(NIH image 1.62; National Institute of Health). The
amount of PI3K-p85α, PI3K-C2α, and Rock-II on the
membrane was expressed as a percentage of the total
value (i.e., membrane fraction plus cytosolic fraction).
Materials and reagents
SEVO and ISO were purchased from Dainabot Company
Limited (Osaka, Japan). Polyclonal antibodies against
phospho-MLC (Thr18/Ser19), phospho-MYPT1 (Thr853),
phospho-MYPT1 (Thr696), phospho-CPI-17 (Thr38),
MLC2 (FL-172), MYPT1 (H-130), CPI-17 (H60), PI3K-
p85α, and Rock-II, and the secondary antibody labeled
with horseradish peroxidase (HRP) were all obtained from
Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA).
PI3K-C2α was purchased from Abcam, Inc. (Tokyo,
Japan). LY294002 was provided from Merck-Calbiochem
Biosciences (Darmstadt, Germany). Y27632 was pur-
chased from Calbiochem-Novabiochem Corporation (San
Diego, CA, USA). All other reagents for experiments and
western blotting were of analytical grade.
Statistical analysis
Data analyses were performed using the software pro-
gram StatMate (Atoms, Tokyo, Japan). The sample
size (n) refers to the number of rats from which the
aortas were harvested. Data are presented as the
mean ± standard deviation and were analyzed using
the Dunnett test after analysis of variance for multiple
comparison of isometric tension or protein phosphor-
ylation. A p-value < 0.05 was considered significant.
Results
KCl induced rapid contraction and reached a maximum
level approximately 5 min after, which was sustained for
more than 30 min in rat aortic rings (Fig. 2). SEVO and ISO
attenuated KCl-induced contraction in a concentration-
dependent manner, and the contraction was also sup-
pressed by LY294002 (1 mM) and Y27632 (1 μM).
There was no statistical difference between SEVO and
ISO when comparing equipotent concentrations (Fig. 3).
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Consistent with the change in isometric force measure-
ments, SEVO and ISO also inhibited MLC phosphoryl-
ation in a concentration-dependent manner in response
to KCl (Fig. 4). SEVO and ISO inhibited membrane
translocation of PI3K-C2α (Fig. 5c and d) and Rock-II
(Fig. 6), but not PI3K-p85 (Fig. 5a and b) in response to
KCl in a concentration-dependent manner in rat aortas.
Both SEVO and ISO inhibited the phosphorylation
MYPT1/Thr853 in response to KCl in a concentration-
dependent manner (Fig. 7). Neither SEVO nor ISO
affected the increase in the phosphorylation of MYPT1/
Thr696 (Fig. 8) and CPI-17/Thr38 (Fig. 9) in response to
KCl.
LY294002 (1 mM) inhibited KCl-induced PI3K-p85
and PI3K-C2α membrane translocation in response to
KCl (p < 0.05, p < 0.01, respectively) (Fig. 5). In addition
to Y27632 (1 μM), LY294002 (1 mM) also inhibited KCl-
induced MLC phosphorylation (Fig. 4) and Rock-II
membrane translocation in rat aortic smooth muscle
(p < 0.01) (Fig. 6).
Fig. 3 Effects of sevoflurane and isoflurane on KCl-induced contraction in rat aortic smooth muscle. The aortas rings were incubated in the presence
of 1.7 %, 3.4 %, 5.1 % sevoflurane (SEVO) or 1.2 %, 2.3 %, 3.5 % isoflurane (ISO), or 1 mM LY294002, or 1 uM Y27632 for 15 min before and
during exposure to KCl. Isometric tension development in response to anesthetic or inhibitor was expressed as percentage relative to that
induced by KCl. * P < 0.05, ** P < 0.01 versus the value in the presence of KCl without anesthetics or inhibitor (n = 7, each)
Fig. 4 Effects of sevoflurane and isoflurane on KCl-induced MLC phosphorylation in rat aortic smooth muscle. The aortas strips were incubated in
the presence of 1.7 %, 3.4 % sevoflurane (SEVO) or 1.2 %, 2.3 % isoflurane (ISO), or 1 mM LY294002, or 1 uM Y27632 for 15 min before and during
exposure to KCl. MLC phosphorylation development in response to anesthetic or inhibitor was expressed as percentage relative to that induced by
KCl. * P < 0.05, ** P < 0.01 versus the value in the presence of KCl without anesthetics or inhibitor, ## P < 0.01 compared with the baseline
without KCl (n = 7, each)
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Discussion and Conclusions
The current study demonstrated that both SEVO and
ISO inhibit KCl-induced MLC phosphorylation and
vasoconstriction by modulating PI3K-C2α and Rho kin-
ase activity in the rat aorta. These findings suggest that
the inhibition of Ca2+-induced Ca2+ sensitization in-
duced by volatile anesthetics contributes to its vasodila-
tory effect.
Several studies demonstrate that LY294002 and
Y27632 inhibit KCl-induced vasoconstriction by sup-
pressing MYPT1 and CPI-17 phosphorylation in rat or
rabbit aortic smooth muscle [8, 11]. LY294002 is similar
to the broad-spectrum PI3K inhibitor wortmannin,
which inhibits class I PI3Ks (α, β, γ, and δ), class II
PI3Ks, and class III PI3Ks [20]. Previous studies have
shown that the PI3K-C2α isoform is less sensitive to
PI3K inhibitors compared with other PI3K isoforms [21,
22]. Therefore, we selected high concentrations of
LY294002 to inhibit PI3K-C2α and MLC phosphoryl-
ation. In this study, our results showed that LY294002
and Y27632 inhibited KCl-induced vasoconstriction by
suppressing MLC phosphorylation and contraction in
rat aortic smooth muscle. We also demonstrated that
LY294002 not only inhibits class II PI3K-C2α, but also
class I PI3K-p85, as well as Rho kinase in response to
KCl, suggesting that PI3K and/or Rho kinase may medi-
ate the inhibition of KCl-induced Ca2+ sensitivity.
Because specific PI3K-C2α-inhibitors do not exist, it re-
mains unclear whether the reduced MLC phosphorylation
and vasoconstriction depends on class II PI3K-C2α-
inhibition or inhibition of class I PI3K.
Accumulating evidence demonstrates that PI3K-C2α
and Rho kinase, or PKC, MYPT1/Thr853, and CPI-17
are involved in vasoconstriction by regulation of Ca2
+-induced Ca2+ sensitization [8, 11, 23–25]. Previous
data indicated that PKC is a major upstream activator of
Fig. 5 Effects of sevoflurane and isoflurane on member translocation of PI3K-C2α and PI3K-p85 in response to KCl. The aortic strips were incubated in the
presence of 0, 1.7 %, 3.4 % sevoflurane (SEVO), or 0, 1.2 %, 2.3 % isoflurane (ISO), or 10 uM, 1 mM LY294002 for 15 min before and during exposure to KCl.
The amount of PI3K-p85α (A and B) and PI3K-C2α (C and D) on the membrane was expressed as a percentage of the total value (i.e., membrane fraction
plus cytosolic fraction). * P< 0.05, ** P< 0.01 versus the value in the presence of KCl, ## P< 0.01 compared with the baseline without KCl (n= 7, each)
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CPI-17 [26, 27]. Takuwa et al. reported that KCl mem-
brane depolarization-induced CPI-17 phosphorylation
was not inhibited by the protein kinase C inhibitor
GF109203X [25]. It seems likely that PKC was not in-
volved in modulating KCl-induced CPI-17 phosphoryl-
ation. Rho kinase can regulate MLCP activity by
influencing MYPT1 phosphorylation at Thr853 and/or
Thr696 [20]. It is possible that the inhibitory effect of
SEVO and ISO on KCl-induced vasoconstriction was
mainly mediated through the Ca2+/PI3K-C2α/Rho kinase/
MYPT1/Thr853 pathway.
Several reports also showed that SEVO decreased
myofilament Ca2+ sensitivity by regulating Rho kinase
and PKC activity [1, 17, 18]. We recently showed that
SEVO does not alter norepinephrine-induced intracellu-
lar Ca2+ changes in the diabetic rat aorta [28]. These
Fig. 7 Effects of sevoflurane and isoflurane on KCl-induced MYPT1/853 phosphorylation in rat aortic smooth muscle. The aortas strips were
incubated in the presence of 1.7 %, 3.4 % sevoflurane (SEVO) or 1.2 %, 2.3 % isoflurane (ISO), or 1 mM LY294002, or 1 uM Y27632 for 15 min before and
during exposure to KCl. MYPT1/853 phosphorylation development in response to anesthetic or inhibitor was expressed as percentage relative to that
induced by KCl. * P < 0.05, ** P < 0.01 versus the value in the presence of KCl without anesthetic or inhibitor, ## P < 0.01 compared with the baseline
without KCl (n = 7, each)
Fig. 6 Effects of sevoflurane and isoflurane on member translocation of Rho kinase (Rock II) in response to KCl. The aortic strips were incubated
in the presence of 0, 1.2 %, 2.3 % isoflurane (ISO,A), or 0, 1.7 %, 3.4 % sevoflurane (SEVO,B), or 1 mM LY294002, or 1 uM Y27632 for 15 min before
and during exposure to KCl. The amount of Rock-II on the membrane was expressed as a percentage of the total value (i.e., membrane fraction
plus cytosolic fraction). * P < 0.05, ** P < 0.01 versus the value in the presence of KCl, # P < 0.05 compared with the baseline without KCl (n = 7, each)
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data further demonstrate that myofilament Ca2+
sensitization, not Ca2+-dependent mechanisms, is in-
volved in modulating vascular tension by SEV.
Evidence also demonstrates that ISO inhibition of
agonist-induced contraction of Ca2+ sensitivity mecha-
nisms is mainly mediated by increasing Ca2+ influx via
voltage-dependent calcium channels [29, 30]. We previ-
ously demonstrated that ISO exhibited no inhibitory
effect on PKC phosphorylation in response to Ang II up
to a concentration of 3.5 % [31]. These data indicate that
ISO-regulated vasoconstriction is mainly through the
Ca2+-dependent pathway and not through the Ca2+ sen-
sitivity pathway. In contrast to the above results, we re-
cently demonstrated that ISO inhibits Ang II-induced
vasoconstriction through regulating the phosphorylation
of the MLCP subunit MYPT1/Thr853 [18]. Furthermore,
Fig. 8 Effects of sevoflurane and isoflurane on KCl-induced MYPT1/696 phosphorylation in rat aortic smooth muscle. The aortas strips were incubated
in the presence of 1.7 %, 3.4 % sevoflurane (SEVO) or 1.2 %, 2.3 % isoflurane (ISO), or 1 mM LY294002, or 1 uM Y27632 for 15 min before and during
exposure to KCl. MYPT1/696 phosphorylation development in response to anesthetic or inhibitor was expressed as percentage relative to
that induced by KCl. ## P < 0.01 compared with the baseline without KCl (n = 7, each)
Fig. 9 Effects of sevoflurane and isoflurane on KCl-induced CPI-17 phosphorylation in rat aortic smooth muscle. The aortas strips were incubated
in the presence of 1.7 %, 3.4 % sevoflurane (SEVO) or 1.2 %, 2.3 % isoflurane (ISO), or 1 mM LY294002, or 1 uM Y27632 for 15 min before and
during exposure to KCl. CPI-17 phosphorylation development in response to anesthetic or inhibitor was expressed as percentage relative
to that induced by KCl. * P < 0.05 versus the value in the presence of KCl, # P < 0.05 versus the baseline without KCl (n = 7, each)
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we demonstrated that ISO inhibits KCl-elicited MLC
phosphorylation and vasoconstriction by suppressing
MYPT1/Thr853, and not CPI-17 phosphorylation in the
rat aorta. These data show that the Ca2+-induced Ca2+
sensitization pathway was also involved in the regulation
of vasoconstriction by ISO.
Overall, our data, in combination with other investiga-
tions, reveal that inhibition of KCl-elicited vasoconstric-
tion by volatile anesthetics may involve the modulation
of PI3K-C2α and/or Rho-Rho kinase activity, the up-
stream activators of MLCP [8, 11, 25]. Consistent with
these data, the current investigation confirmed that both
SEVO and ISO suppress the vasoconstriction of Ca2+-in-
duced Ca2+ sensitization through modulating PI3K-C2α,
Rho kinase activity, and MYPT1/Thr853 phosphoryl-
ation in rat vascular smooth muscle.
However, this study has some limitations: (1) the aim
of this study was to elucidate the cellular mechanisms
responsible for anesthetic-induced inhibition of vasocon-
striction. Therefore, we used endothelium-denuded aor-
tic strips or rings for this study. Indeed, the endothelium
plays an important role in regulating systemic vascular
tone under in vivo conditions. However, we used
endothelium-denuded samples to avoid the effects of the
endothelium. (2) Moreover, pre-arteriolar resistance ar-
teries, not conduit arteries, mainly determine peripheral
vascular resistance. Therefore, the current results ob-
tained from endothelium-denuded aortas cannot be used
to directly extrapolate to the in vivo condition. (3) Fur-
thermore, the aortic rings are not necessarily reflective
of the physiology of resistance arteries and thus may not
be ideally suited to address issues related to the clinical
hemodynamic effects of volatile anesthetics.
In conclusion, our study demonstrates that both SEVO
and ISO inhibit KCl-induced PI3K-C2α-participation,
Rho kinase-mediated MLC phosphorylation, and vasocon-
striction in rat aortic smooth muscle. The intracellular
mechanisms of regulating VSM contraction of volatile
anesthetics may be mediated by the KCl/PI3K-C2α/Rho
kinase/MLCP/MLC pathway.
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